Skip to main content
Erschienen in: Tumor Biology 1/2011

01.02.2011 | Research Article

Part I. Development of a model system for studying nitric oxide in tumors: high nitric oxide-adapted head and neck squamous cell carcinoma cell lines

verfasst von: Yaroslav R. Yarmolyuk, Benjamin J. Vesper, William A. Paradise, Kim M. Elseth, Gabor Tarjan, G. Kenneth Haines III, James A. Radosevich

Erschienen in: Tumor Biology | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

The free radical nitric oxide (NO) is over-expressed in many tumors, including head and neck squamous cell carcinomas (HNSCC); however, the role NO plays in tumor pathophysiology is still not well understood. We, herein, report the development of an in vitro model system which can be used to probe the role of NO in the carcinogenesis of HNSCC. Five HNSCC cell lines were adapted to a high NO (HNO) environment by gradually introducing increasing concentrations of DETA-NONOate, a nitrogen-based NO donor, to cell media. The adaptation process was carried out until a sufficiently high enough donor concentration was reached which enabled the HNO cells to survive and grow, but which was lethal to the original, unadapted (“parent”) cells. The adapted HNO cells exhibited analogous morphology to the parent cells, but grew better than their corresponding parent cells in normal media, on soft agar, and in the presence of hydrogen peroxide, an oxygen-based free radical donor. These results indicate that the HNO cell lines are unique and possess biologically different properties than the parent cell lines from which they originated. The HNO/parent cell lines developed herein may be used as a model system to better understand the role NO plays in HNSCC carcinogenesis.
Literatur
3.
Zurück zum Zitat Pryor WA. Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity. Environ Health Perspect. 1997;105 Suppl 4:875–82.CrossRefPubMed Pryor WA. Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity. Environ Health Perspect. 1997;105 Suppl 4:875–82.CrossRefPubMed
4.
Zurück zum Zitat Church DF, Pryor WA. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect. 1985;64:111–26.CrossRefPubMed Church DF, Pryor WA. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect. 1985;64:111–26.CrossRefPubMed
5.
Zurück zum Zitat Culcasi M, Muller A, Mercier A, Clement JL, Payet O, Rockenbauer A, et al. Early specific free radical-related cytotoxicity of gas phase cigarette smoke and its paradoxical temporary inhibition by tar: An electron paramagnetic resonance study with the spin trap depmpo. Chem Biol Interact. 2006;164:215–31.CrossRefPubMed Culcasi M, Muller A, Mercier A, Clement JL, Payet O, Rockenbauer A, et al. Early specific free radical-related cytotoxicity of gas phase cigarette smoke and its paradoxical temporary inhibition by tar: An electron paramagnetic resonance study with the spin trap depmpo. Chem Biol Interact. 2006;164:215–31.CrossRefPubMed
7.
Zurück zum Zitat Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39:44–84.CrossRefPubMed Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39:44–84.CrossRefPubMed
8.
Zurück zum Zitat Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006;160:1–40.CrossRefPubMed Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006;160:1–40.CrossRefPubMed
9.
Zurück zum Zitat Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109–42.PubMed Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109–42.PubMed
10.
Zurück zum Zitat Higashi Y, Noma K, Yoshizumi M, Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ J. 2009;73:411–8.CrossRefPubMed Higashi Y, Noma K, Yoshizumi M, Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ J. 2009;73:411–8.CrossRefPubMed
11.
Zurück zum Zitat Forstermann U. Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat Clin Pract Cardiovasc Med. 2008;5:338–49.CrossRefPubMed Forstermann U. Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat Clin Pract Cardiovasc Med. 2008;5:338–49.CrossRefPubMed
12.
Zurück zum Zitat Mocellin S. Nitric oxide: cancer target or anticancer agent? Curr Cancer Drug Targets. 2009;9:214–36.CrossRefPubMed Mocellin S. Nitric oxide: cancer target or anticancer agent? Curr Cancer Drug Targets. 2009;9:214–36.CrossRefPubMed
13.
Zurück zum Zitat Thomsen LL, Lawton FG, Knowles RG, Beesley JE, Riveros-Moreno V, Moncada S. Nitric oxide synthase activity in human gynecological samples. Cancer Res. 1994;54:1352–4.PubMed Thomsen LL, Lawton FG, Knowles RG, Beesley JE, Riveros-Moreno V, Moncada S. Nitric oxide synthase activity in human gynecological samples. Cancer Res. 1994;54:1352–4.PubMed
14.
Zurück zum Zitat Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, Moncada S. Nitric oxide synthase in human breast cancer. Br J Cancer. 1995;72:41–4.PubMed Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, Moncada S. Nitric oxide synthase in human breast cancer. Br J Cancer. 1995;72:41–4.PubMed
15.
Zurück zum Zitat Cobbs CS, Brenman JE, Aldape KD, Bredt DS, Israel MA. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res. 1994;55:727–30. Cobbs CS, Brenman JE, Aldape KD, Bredt DS, Israel MA. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res. 1994;55:727–30.
16.
Zurück zum Zitat Ambs S, Merriam WG, Bennet WP, Felley-Bosco E, Ogunfusika MO, Oser SM, et al. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res. 1998;58:334–41.PubMed Ambs S, Merriam WG, Bennet WP, Felley-Bosco E, Ogunfusika MO, Oser SM, et al. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res. 1998;58:334–41.PubMed
17.
Zurück zum Zitat Ambs S, Bennett WP, Merriam WG, Ogunfusika MO, Oser SM, Khan MA, et al. Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53. Br J Cancer. 1998;78:233–9.CrossRefPubMed Ambs S, Bennett WP, Merriam WG, Ogunfusika MO, Oser SM, Khan MA, et al. Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53. Br J Cancer. 1998;78:233–9.CrossRefPubMed
18.
Zurück zum Zitat Beevi SS, Rasheed MH, Geetha A. Evidence of oxidative and nitrosative stress in patients with cervical squamous cell carcinoma. Clin Chim Acta. 2007;375:119–23.CrossRefPubMed Beevi SS, Rasheed MH, Geetha A. Evidence of oxidative and nitrosative stress in patients with cervical squamous cell carcinoma. Clin Chim Acta. 2007;375:119–23.CrossRefPubMed
19.
Zurück zum Zitat Bentz BG, Haines III GK, Lingen MW, Pelzer HJ, Hanson DG, Radosevich JA. Nitric oxide synthase type 3 is increased in squamous hyperplasia, dysplasia, and squamous cell carcinoma of the head and neck. Ann Otol Rhinol Laryngol. 1999;108:781–7.PubMed Bentz BG, Haines III GK, Lingen MW, Pelzer HJ, Hanson DG, Radosevich JA. Nitric oxide synthase type 3 is increased in squamous hyperplasia, dysplasia, and squamous cell carcinoma of the head and neck. Ann Otol Rhinol Laryngol. 1999;108:781–7.PubMed
20.
Zurück zum Zitat Bentz BG, Haines III GK, Hanson DG, Radosevich JA. Endothelial constitutive nitric oxide synthase (ecnos) localization in normal and neoplastic salivary tissue. Head Neck. 1998;20:304–9.CrossRefPubMed Bentz BG, Haines III GK, Hanson DG, Radosevich JA. Endothelial constitutive nitric oxide synthase (ecnos) localization in normal and neoplastic salivary tissue. Head Neck. 1998;20:304–9.CrossRefPubMed
21.
Zurück zum Zitat Chandra R, Haines III GK, Bentz BG, Shah P, Robinson AM, Radosevich JA. Expression of nitric oxide synthase type 3 in reflux-induced esophageal lesions. Otolaryngol Head Neck Surg. 2001;124:442–7.CrossRefPubMed Chandra R, Haines III GK, Bentz BG, Shah P, Robinson AM, Radosevich JA. Expression of nitric oxide synthase type 3 in reflux-induced esophageal lesions. Otolaryngol Head Neck Surg. 2001;124:442–7.CrossRefPubMed
22.
Zurück zum Zitat Kizilay A, Kalcioglu MT, Ozugurlu F, Ozyurt H, Aladag I, Ozturan O, et al. Serum nitric oxide levels in patients with head and neck squamous cell carcinoma. Kulak Burun Bogaz Ihtis Derg. 2007;17:148–51.PubMed Kizilay A, Kalcioglu MT, Ozugurlu F, Ozyurt H, Aladag I, Ozturan O, et al. Serum nitric oxide levels in patients with head and neck squamous cell carcinoma. Kulak Burun Bogaz Ihtis Derg. 2007;17:148–51.PubMed
23.
Zurück zum Zitat Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, et al. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA. 1995;92:4392–6.CrossRefPubMed Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, et al. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA. 1995;92:4392–6.CrossRefPubMed
24.
Zurück zum Zitat Thomas DD, Ridnour LA, Isenberg JS, Flores-Santana W, Switzer CH, Donzelli S, et al. The chemical biology of nitric oxide: implications in cellular signaling. Free Radic Biol Med. 2008;45:18–31.CrossRefPubMed Thomas DD, Ridnour LA, Isenberg JS, Flores-Santana W, Switzer CH, Donzelli S, et al. The chemical biology of nitric oxide: implications in cellular signaling. Free Radic Biol Med. 2008;45:18–31.CrossRefPubMed
25.
Zurück zum Zitat Wink DA, Vodovotz Y, Laval J, Laval F, Dewhirst MW, Mitchell JB. The multifaceted roles of nitric oxide in cancer. Carcinogenesis. 1998;19:711–21.CrossRefPubMed Wink DA, Vodovotz Y, Laval J, Laval F, Dewhirst MW, Mitchell JB. The multifaceted roles of nitric oxide in cancer. Carcinogenesis. 1998;19:711–21.CrossRefPubMed
26.
Zurück zum Zitat Radosevich JA, Elseth KM, Vesper BJ, Tarjan G, Haines III GK. Long-term adaptation of lung tumor cell lines with increasing concentrations of nitric oxide donor. The Open Lung Cancer Journal. 2009;2:35–44.CrossRef Radosevich JA, Elseth KM, Vesper BJ, Tarjan G, Haines III GK. Long-term adaptation of lung tumor cell lines with increasing concentrations of nitric oxide donor. The Open Lung Cancer Journal. 2009;2:35–44.CrossRef
27.
Zurück zum Zitat Vesper BJ, Elseth KM, Tarjan G, Haines III GK, Radosevich JA. Long-term adaptation of breast tumor cell lines to high concentrations of nitric oxide. Tumor Biol. 2010;31:267–75.CrossRef Vesper BJ, Elseth KM, Tarjan G, Haines III GK, Radosevich JA. Long-term adaptation of breast tumor cell lines to high concentrations of nitric oxide. Tumor Biol. 2010;31:267–75.CrossRef
28.
Zurück zum Zitat Huang X, Gollin SM, Raja S, Godfrey TE. High-resolution mapping of the 11q13 amplicon and identification of a gene, taos1, that is amplified and overexpressed in oral cancer cells. Proc Natl Acad Sci USA. 2002;99:11369–74.CrossRefPubMed Huang X, Gollin SM, Raja S, Godfrey TE. High-resolution mapping of the 11q13 amplicon and identification of a gene, taos1, that is amplified and overexpressed in oral cancer cells. Proc Natl Acad Sci USA. 2002;99:11369–74.CrossRefPubMed
29.
Zurück zum Zitat Bentz BG, Hammer ND, Milash B, Klein S, Burnett DM, Radosevich JA, et al. The kinetics and redox state of nitric oxide determine the biological consequences in lung adenocarcinoma. Tumor Biol. 2007;28:301–11.CrossRef Bentz BG, Hammer ND, Milash B, Klein S, Burnett DM, Radosevich JA, et al. The kinetics and redox state of nitric oxide determine the biological consequences in lung adenocarcinoma. Tumor Biol. 2007;28:301–11.CrossRef
30.
Zurück zum Zitat Tarjan G, Haines III GK, Vesper BJ, Xue J, Altman MB, Yarmolyuk Y, et al. Part II. Initial molecular and cellular characterization of high nitric oxide-adapted human tongue squamous cell carcinoma cell lines. Tumor Biol. 2010. doi:10.1007/s13277-010-0102-0. Tarjan G, Haines III GK, Vesper BJ, Xue J, Altman MB, Yarmolyuk Y, et al. Part II. Initial molecular and cellular characterization of high nitric oxide-adapted human tongue squamous cell carcinoma cell lines. Tumor Biol. 2010. doi:10.​1007/​s13277-010-0102-0.
Metadaten
Titel
Part I. Development of a model system for studying nitric oxide in tumors: high nitric oxide-adapted head and neck squamous cell carcinoma cell lines
verfasst von
Yaroslav R. Yarmolyuk
Benjamin J. Vesper
William A. Paradise
Kim M. Elseth
Gabor Tarjan
G. Kenneth Haines III
James A. Radosevich
Publikationsdatum
01.02.2011
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 1/2011
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-010-0101-1

Weitere Artikel der Ausgabe 1/2011

Tumor Biology 1/2011 Zur Ausgabe

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.